92901-94-5

Basic information

• Product Name: (2,5-DIMETHYL-1,3-OXAZOL-4-YL)METHANOL
• Synonyms: (2,5-DIMETHYL-1,3-OXAZOL-4-YL)METHANOL;(2,5-Dimethyl-1,3-oxazol-4-yl)methanol 97%;2,5-Dimethyl-4-(hydroxymethyl)-1,3-oxazole;(2,5-Dimethyloxazol-4-yl)methanol;2,5-Dimethyl-4-(hydroxymethyl)-1,3-oxazole 97%;2,5-Dimethyl-4-(hydroxymethyl)-1,3-oxazole97%
• CAS NO: 92901-94-5
• Molecular Formula: C₆H₉NO₂
• Molecular Weight: 127.14
• EINECS: 200-258-5
• Mol File: 92901-94-5.mol

Chemical Properties

• Melting Point: 73 °C
• Boiling Point: 222.012 °C at 760 mmHg
• Flash Point: 88.07 °C
• Appearance: /
• Density: 1.137 g/cm³
• Vapor Pressure: 0.06mmHg at 25°C
• Refractive Index: 1.497
• Storage Temp.: 2-8°C
• PKA: 13.15±0.10(Predicted)
• CAS DataBase Reference: (2,5-DIMETHYL-1,3-OXAZOL-4-YL)METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (2,5-DIMETHYL-1,3-OXAZOL-4-YL)METHANOL(92901-94-5)
• EPA Substance Registry System: (2,5-DIMETHYL-1,3-OXAZOL-4-YL)METHANOL(92901-94-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• Hazardous Substances Data: 92901-94-5(Hazardous Substances Data)

Usage

Uses

Given the provided materials, there are no specific applications or uses mentioned for (2,5-DIMETHYL-1,3-OXAZOL-4-YL)METHANOL. However, based on its chemical structure and belonging to the class of oxazoles, it may have potential applications in various industries, such as pharmaceuticals, materials science, or chemical research. Further investigation and research would be required to explore and confirm its potential uses and benefits in these or other industries.

InChI:InChI=1/C6H9NO2/c1-4-6(3-8)7-5(2)9-4/h8H,3H2,1-2H3

Upstream product

• 23000-14-8 2,5-dimethyl-1,3-oxazole-4-carboxylic acid 
• 23000-15-9 2,5-Dimethyl-4-oxazolcarbonsaeure-ethylester 
• 141567-53-5 4-hydroxymethyl-2-methyloxazole 
• 333-27-7 methyl trifluoromethanesulfonate 
• 5431-93-6 ethyl 2-(acetylamino)-3-oxobutanoate 
• 98432-01-0 methyl 2-acetamido-3-oxobutanoate 

Downstream Products

• 92901-90-1 (2,5-Dimethyl-4-oxazolyl)<1-(ethoxymethyl)-2(phenylthio)-1H-imidazol-5-yl>methanone 
• 92901-89-8 α-<1-(Ethoxymethyl)-2-(phenylthio)-1H-imidazol-5-yl>-2,5-dimethyl-4-oxazolemethanol 
• 1026742-99-3 C₄₀H₆₈N₆O₈SSi 
• 940879-52-7 3-{[(2,5-dimethyloxazol-4-yl)methyl]carbamoyl}-5-(N-methylmethan-5-ylsulfonamido)benzoic acid 
• 1026044-87-0 C₁₇H₂₁N₃O₆S 
• 859850-62-7 2,5-dimethyloxazol-4-ylmethanamine 

Relevant articles and documents

Synthesis and evaluation of a novel series of 2,7-substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives as selective peroxisome proliferator-activated receptor γ partial agonists

A novel series of 7-substituted-2-[3-(2-furyl)acryloyl]-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives were synthesized to clarify structure–activity relationships for peroxisome proliferator-activated receptor γ (PPARγ) partial agonist activity

Amino-Containing Compounds Which Inhibit Memapsin 2 Beta-Secretase Activity and Methods of Use Thereof

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease.

Design, synthesis and X-ray structure of protein-ligand complexes: Important insight into selectivity of memapsin 2 (β-secretase) inhibitors

Structure-based design, synthesis, and X-ray structure of protein-ligand complexes of memapsin 2 are described. The inhibitors are designed specifically to interact with S2- and S3-active site residues to provide selectivity over mem

BICYCLIC COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF

The present invention provides bicyclic beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer’s disease.

Selective lithiation of 2-methyloxazoles. Applications to pivotal bond constructions in the phorboxazole nucleus

(equation presented) R = Alkyl, Vinyl, Aryl 6:7 >95:5 The lithiation of 2-methyloxazoles with alkyllithium and hindered lithium amide bases generally results in the competitive formation of a mixture of 5-lithio-and 2-(lithiomethyl)oxazole isomers. Herein a synthetically useful lithiation method which allows for the selective formation of 2-(lithiomethyl)oxazole is described. Diethylamine has been found to be a kinetically competent proton source that will mediate the equilibration of the kinetically formed 5-lithiooxazole to its more stable 2-(lithiomethyl)oxazole counterpart. Application of this metalation strategy with lithium diethylamide to two important bond constructions relevant to a projected phorboxazole synthesis is presented.